We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
1501
Baker Hughes
BKR
$61.1B
$8K ﹤0.01%
+347
New +$8.14K
KDP icon
1502
CALL
Keurig Dr Pepper
KDP
$40.8B
$8K ﹤0.01%
300
ROST icon
1503
Ross Stores
ROST
$81.9B
$8K ﹤0.01%
69
-144
-68% -$15.2K
RRR icon
1504
CALL
Red Rock Resorts
RRR
$3.62B
$8K ﹤0.01%
+400
New +$8.35K
SCPH
1505
DELISTED
scPharmaceuticals
SCPH
$8K ﹤0.01%
+1,300
New +$7.33K
CNR
1506
Core Natural Resources Inc
CNR
$4.45B
$8K ﹤0.01%
+540
New +$10.6K
ALBO
1507
DELISTED
Albireo Pharma Inc
ALBO
$8K ﹤0.01%
378
-442
-54% -$11.4K
MIME
1508
DELISTED
Mimecast Limited
MIME
$8K ﹤0.01%
216
-84
-28% -$3.65K
PFPT
1509
DELISTED
Proofpoint, Inc.
PFPT
$8K ﹤0.01%
+60
New +$7.34K
GSUM
1510
DELISTED
Gridsum Holding Inc.
GSUM
$8K ﹤0.01%
4,890
AUTL
1511
Autolus Therapeutics
AUTL
$562M
$7K ﹤0.01%
540
-50
-8% -$661
CNDT icon
1512
CALL
Conduent
CNDT
$264M
$7K ﹤0.01%
1,100
+500
+83% +$3.87K
CVLT icon
1513
Commault Systems
CVLT
$5.61B
$7K ﹤0.01%
+150
New +$6.87K
EPAM icon
1514
EPAM Systems
EPAM
$5.03B
$7K ﹤0.01%
+40
New +$7.53K
FRO icon
1515
PUT
Frontline
FRO
$8.85B
$7K ﹤0.01%
800
-500
-38% -$4.04K
INSM icon
1516
Insmed
INSM
$28.6B
$7K ﹤0.01%
421
-41,333
-99% -$798K
MEC icon
1517
Mayville Engineering Co
MEC
$617M
$7K ﹤0.01%
+500
New +$6.68K
NGVT icon
1518
Ingevity
NGVT
$2.68B
$7K ﹤0.01%
83
-1,158
-93% -$103K
OEC icon
1519
Orion
OEC
$409M
$7K ﹤0.01%
+432
New +$7.07K
OOMA icon
1520
Ooma
OOMA
$604M
$7K ﹤0.01%
700
-1,457
-68% -$17.1K
SPRO icon
1521
Spero Therapeutics
SPRO
$73M
$7K ﹤0.01%
700
+200
+40% +$2.11K
VNDA icon
1522
Vanda Pharmaceuticals
VNDA
$302M
$7K ﹤0.01%
540
-406
-43% -$5.66K
VVV icon
1523
Valvoline
VVV
$4.51B
$7K ﹤0.01%
+300
New +$6.44K
WDAY icon
1524
Workday
WDAY
$44.4B
$7K ﹤0.01%
+39
New +$7.53K
EPZM
1525
DELISTED
Epizyme, Inc
EPZM
$7K ﹤0.01%
702
-71,998
-99% -$908K

Similar funds

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.